PharmGKB Blog
Wednesday, April 29, 2020

Join the new PGRN society!

›
After 20 years of NIH funding, the Pharmacogenomics Research Network (PGRN) is transitioning to an independent, nonprofit scientific societ...
Friday, April 17, 2020

Therapeutic Resource for COVID-19

›
PharmGKB has assembled a COVID-19 webpage containing therapeutic drugs from clinical trials and adjuvant therapies linking to PharmGKB anno...
Monday, April 13, 2020

National COVID-19 daily health survey launched by Stanford Medicine

›
Stanford Medicine researchers have released a daily survey to help predict surges of COVID-19 cases in the United States. The Stanford ...
Wednesday, March 25, 2020

New CPIC Guideline: CYP2C9 and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

›
The CPIC Guideline for  CYP2C9  and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)  is now published in  Clinical Pharmacology and Therap...
Monday, March 23, 2020

Lamotrigine pathway published in Pharmacogenetics and Genomics

›
The PharmGKB lamotrigine pathway has been recently published in the journal Pharmacogenetics and Genomics . The publication, written by...
Sunday, February 23, 2020

FDA releases tables on the use of pharmacogenetic testing for specific medications

›
CPIC and PharmGKB applaud the release of additional guidance from the FDA on the use of pharmacogenetic testing for specific medications . ...
Monday, February 10, 2020

Centralized presentation material repository now available from CPIC’s PGx Dissemination working group

›
The CPIC’s PGx Dissemination working group has developed a central repository for pharmacogenomic-related presentation material...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.